These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23869062)

  • 21. Evaluating the effects of hormone therapy termination on skeletal muscle and physical independence in postmenopausal women.
    Wullems JA; Degens H; Morse CI; Onambélé-Pearson GL
    Menopause; 2024 Jun; 31(6):546-555. PubMed ID: 38713886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prolonged hiatus in postmenopausal HRT, does not nullify the therapy's positive impact on ageing related sarcopenia.
    Onambélé-Pearson GL; Tomlinson DJ; Morse CI; Degens H
    PLoS One; 2021; 16(5):e0250813. PubMed ID: 33951065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefits of hormone replacement therapy in postmenopausal women.
    Canderelli R; Leccesse LA; Miller NL; Unruh Davidson J
    J Am Acad Nurse Pract; 2007 Dec; 19(12):635-41. PubMed ID: 18042129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone therapy attenuates exercise-induced skeletal muscle damage in postmenopausal women.
    Dieli-Conwright CM; Spektor TM; Rice JC; Sattler FR; Schroeder ET
    J Appl Physiol (1985); 2009 Sep; 107(3):853-8. PubMed ID: 19574506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmenopausal hormone therapy and coronary heart disease in early postmenopausal women.
    Tuomikoski P; Mikkola TS
    Ann Med; 2014 Feb; 46(1):1-7. PubMed ID: 24266727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen influences on neuromuscular function in postmenopausal women.
    Sipilä S; Finni T; Kovanen V
    Calcif Tissue Int; 2015 Mar; 96(3):222-33. PubMed ID: 25359124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Withdrawal of hormone therapy and increased risk of cardiovascular disease.
    Pines A
    Climacteric; 2016 Jun; 19(3):249-51. PubMed ID: 27075839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y).
    Vaughan L; Espeland MA; Snively B; Shumaker SA; Rapp SR; Shupe J; Robinson JG; Sarto GE; Resnick SM;
    Brain Res; 2013 Jun; 1514():3-11. PubMed ID: 23578696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmenopausal hormone therapy and cognition.
    McCarrey AC; Resnick SM
    Horm Behav; 2015 Aug; 74():167-72. PubMed ID: 25935728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
    Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
    Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current recommendations: what is the clinician to do?
    Manson JE
    Fertil Steril; 2014 Apr; 101(4):916-21. PubMed ID: 24680650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menopausal hormone therapy.
    Bhavnani BR; Strickler RC
    J Obstet Gynaecol Can; 2005 Feb; 27(2):137-62. PubMed ID: 15937590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmenopausal hormone therapy and migraine headache.
    Misakian AL; Langer RD; Bensenor IM; Cook NR; Manson JE; Buring JE; Rexrode KM
    J Womens Health (Larchmt); 2003 Dec; 12(10):1027-36. PubMed ID: 14709191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.
    Wild RA; Wu C; Curb JD; Martin LW; Phillips L; Stefanick M; Trevisan M; Manson JE
    Menopause; 2013 Mar; 20(3):254-60. PubMed ID: 23435021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances help understand and improve the safety of menopausal therapies.
    Mirkin S; Archer DF; Pickar JH; Komm BS
    Menopause; 2015 Mar; 22(3):351-60. PubMed ID: 25051290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drugs for the treatment of postmenopausal symptoms: Hormonal and non-hormonal therapy.
    Pan M; Zhou J; Pan X; Wang J; Qi Q; Wang L
    Life Sci; 2023 Jan; 312():121255. PubMed ID: 36470539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.